These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29413947)

  • 1. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
    Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
    Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
    Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
    Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
    Lyu WJ; Shu YJ; Liu YB; Dong P
    Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma.
    Zhao Y; Yang L; He J; Yang H
    Tumour Biol; 2017 Jul; 39(7):1010428317711644. PubMed ID: 28720063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
    Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
    Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
    Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
    Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
    Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
    Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.
    Li H; Zhang Y; Hai J; Wang J; Zhao B; Du L; Geng X
    Biomed Pharmacother; 2018 Jul; 103():1272-1278. PubMed ID: 29864908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells.
    Zhou J; Wang F; Liu B; Yang L; Wang X; Liu Y
    Oncol Res; 2017 Jul; 25(6):931-937. PubMed ID: 27983928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN.
    Sheng S; Jiwen W; Dexiang Z; Bohao Z; Yueqi W; Han L; Xiaoling N; Tao S; Liu H
    Biosci Biotechnol Biochem; 2019 Dec; 83(12):2257-2264. PubMed ID: 31411121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling.
    Song X; Wang Z; Liang H; Zhang W; Ye Y; Li H; Hu Y; Zhang Y; Weng H; Lu J; Wang X; Li M; Liu Y; Gu J
    Int J Biol Sci; 2017; 13(6):782-793. PubMed ID: 28656003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.
    Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W
    Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway.
    Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y
    Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth.
    Zhang Y; Liu S; Wang L; Wu Y; Hao J; Wang Z; Lu W; Wang XA; Zhang F; Cao Y; Liang H; Li H; Ye Y; Ma Q; Zhao S; Shu Y; Bao R; Jiang L; Hu Y; Zhou J; Chen L; Liu Y
    Cancer Lett; 2016 May; 375(1):179-189. PubMed ID: 26949052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
    Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
    J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
    Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
    J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.